SAN FRANCISCO, CA–(Marketwire – October 4, 2010) –  Presidiohealth, which offers real-time, mobile computing performance management solutions for healthcare providers, announced today the launch of PerformCycle™, a new patient care management tool that provides an interactive, measurable action plan for pediatric asthma patients.

Presidio is launching the core service this month in the Pediatric Emergency Department at California Pacific Medical Center in San Francisco. Daily monitoring of the child’s status, triggers, and medication use seeks to provide better quality care, reduce emergency visits and hospitalizations, and lower overall healthcare and social costs. The PerformCycle platform combines evidence-based care guidelines, the Asthma Action Plan, and post-care patient tracking (CareTracker) solutions to offer home monitoring of a child’s post-care progress and share direct patient feedback with healthcare providers in the emergency department and the pediatrics office. For patients whose parents don’t have smartphones, the basic service delivers daily monitoring and reminders via two way communication with text message and e-mail. For iPhone users, CareTracker integrates the free AsthmaMD™ app.

“We are proud to be part of the first wave of healthcare innovation that brings the patient into the middle of the care cycle,” said Presidiohealth founder and president Douglas Evans. “As an ER physician, I know firsthand why delivering high quality care demands an interaction between provider best practices, enhanced patient education, and ongoing patient engagement. By combining our PerformCycle solutions with the exploding marketplace of mobile apps, we expect to offer health care providers and their patient communities new tools for enhancing care quality and clinical outcomes.” 

“All signs indicate healthcare is at the beginning of a revolution, called mHealth,” said Peter Waegemann, CEO of Medical Records Institute. “Communication-enhanced healthcare is a major part of this development. As new disease management methods emerge that integrate continuous sensing of data, provider monitoring and patient reporting, quality of care will improve and healthcare costs will be lowered. This has been proven in diabetes and hypertension management, but applies equally to asthma management.”

PerformCycle will be available immediately to pediatric asthma patients at California Pacific Medical Center, and beyond CPMC later this year. It will eventually expand to other high-cost-burden diseases. Dr. Evans will present the PerformCycle pilot project on the “Tools for Care Management” panel at the Health 2.0 Conference in San Francisco on October 7 and 8, 2010.

About Presidiohealth
Presidiohealth was founded in 2004 with the primary mission of providing performance management solutions for healthcare providers. Using SaaS and cloud technologies, the company consolidates critical business information so clients can manage clinical and revenue performance in one system. In addition to PerformCycle, Presidio’s services include PerformPOS™, PerformMD™, and PerformRN™ solutions. For more information, visit www.presidiohealth.com.

Click here to see all recent news from this company

HOUSTON, TX–(Marketwire – October 4, 2010) – SHAPE, The Society for Heart Attack Prevention and Eradication (http://www.shapesociety.org), a nonprofit organization that promotes the early detection and treatment of heart attack risk in apparently healthy people, today announced three clinics have achieved certification as SHAPE/HeartHealth Centers of Excellence. The newly certified clinics are Bon Secours Reynolds Crossing Imaging Center in Richmond, Va., Bon Secours St. Francis Hospital in Midlothian, Va., and St. John’s Heart Institute in Springfield, Mo.

The SHAPE/HeartHealth Centers of Excellence initiative encourages best practices in heart attack screening. To be considered for SHAPE/HeartHealth Centers of Excellence certification, a clinic must be committed to improving patient outcomes through early detection and primary prevention of coronary artery disease (CAD). Unlike traditional cardiovascular clinics that are primarily focused on preventing a second heart attack, SHAPE/HeartHealth Centers of Excellence focus on the prevention of a first heart attack — especially in the vulnerable population, those at risk of a near future heart attack.

“We congratulate these clinics on helping to advance preventive cardiology through the responsible practice of cardiovascular screening,” said JoAnne Zawitoski, chairwoman of the SHAPE Board of Directors. “Through these SHAPE/HeartHealth Centers of Excellence we are making progress toward preventing and, ultimately, eradicating heart attacks, but we have a very long way to go.”

SHAPE/HeartHealth Centers of Excellence adhere to the First SHAPE Guideline for screening to identify hidden CAD in apparently healthy individuals. The First SHAPE Guideline established standards for the careful and responsible implementation of scientifically proven atherosclerosis tests to detect hidden plaque buildup in coronary and carotid arteries, and recommended the tests be incorporated into routine screening for at risk men and women as they age.

In addition to the newly certified clinics, other SHAPE/HeartHealth Centers of Excellence are located in Arizona, Florida and Pennsylvania.

The SHAPE/HeartHealth Centers of Excellence Program coincides with SHAPE Provider Certification. For more information about these certification programs for your practice or hospital, please contact Dr. Jeff Fine at (803) 360-4756 or [email protected].

About SHAPE

Based in Houston, the Society for Heart Attack Prevention and Eradication (SHAPE) is a non-profit organization that promotes education and research related to prevention, detection, and treatment of heart attacks. SHAPE is committed to raising public awareness about revolutionary discoveries that are opening exciting avenues to prevent heart attacks. SHAPE’s mission is to eradicate heart attacks in the 21st century. Additional information is available on the organization’s Web site at www.shapesociety.org.

Click here to see all recent news from this company

ATLANTA, GA–(Marketwire – October 4, 2010) –  Uni-Ter Underwriting Management Corporation (UUMC), builder and manager of Risk Retention Groups in the healthcare industry, won the Computer Sciences Corporation (CSC) award for innovation in the process of customizing the CSC RISKMASTER X policy administration and claims processing software to reduce UUMC operational costs and increase efficiency.

According to the award citation, “Integrating all facets of the business will improve continuity and structure within the organization. UUMC has used the expertise that CSC has earned through its 50 years of industry experience to evaluate its business practices and establish guidelines to ensure that day-to-day operations are handled consistently and adequately. As a result of this process, UUMC has determined that integrating additional CSC products may be desired to achieve the all-inclusive system that would set UUMC apart from its competitors. A second phase project plan has already been initiated.”

The award was presented at CSC’s annual Connect Conference held in Kissimmee, Fl. The conference was attended by some 1,500 representatives of companies that do business with CSC.

KANSAS CITY, MO–(Marketwire – October 4, 2010) –  The Ewing Marion Kauffman Foundation will release several studies over the next month on various aspects of health care. Topics range from a call for a personalized health manifesto to employer-based health insurance effects on business creation and an analysis of the costs and benefits of the health care reform bill’s expanded comparative effectiveness research. Highlights of these studies are outlined below. Please contact us if you are interested in specific reports or would like advance copies.

• The Personalized Health Manifesto. Billed as “an old-fashioned call to arms and action plan for a new age of health care,” the paper says there is a “new urgency for scientists to work together to focus on the whole human organism… and for society to absorb and implement scientific discoveries.” The Manifesto is an outgrowth of a larger study, and it calls on the life science community, policymakers, patients and society at large to take a list of actions to accelerate a transformation to personalized health.

• Is Employer-based Health Insurance a Barrier to Entrepreneurship? This study asks whether employer-based health insurance has a negative effect on business creation by causing “job lock” in which workers may be reluctant to risk health coverage by leaving their jobs to start a company. The study examines the issue from several demographic factors, including gender and age, and raises concerns about how the bundling of health insurance and employment impacts business creation.

• Promoting Comparative Effectiveness Research. This study addresses how to make the new health care reform law’s expansion of the comparative effectiveness research (CER) work best or to cause the least amount of harm. CER is research that attempts to analyze which treatment options are more effective than others in terms of quality and cost. A major focus of this study is on market-oriented, patient-centered approaches for disseminating and implementing CER to enhance health outcomes efficiently while preserving patient choice.

• The New Role of Academia in Drug Development. The process for taking scientific discoveries from university labs to the market is stagnant and faces many obstacles. This paper outlines observations presented at a recent town hall meeting held at the Kauffman Foundation and presents recommendations for policymakers and thought leaders on how new collaboration models will benefit cancer cures and treatments. More information on the town hall meeting can be found here.

About the Kauffman Foundation
The Ewing Marion Kauffman Foundation is a private nonpartisan foundation that works to harness the power of entrepreneurship and innovation to grow economies and improve human welfare. Through its research and other initiatives, the Kauffman Foundation aims to open young people’s eyes to the possibility of entrepreneurship, promote entrepreneurship education, raise awareness of entrepreneurship-friendly policies, and find alternative pathways for the commercialization of new knowledge and technologies. In addition, the Foundation focuses on initiatives in the Kansas City region to advance students’ math and science skills, and improve the educational achievement of urban students, including the Ewing Marion Kauffman School, a college preparatory charter school for middle and high school students set to open in 2011. Founded by late entrepreneur and philanthropist Ewing Marion Kauffman, the Foundation is based in Kansas City, Mo. and has approximately $2 billion in assets. For more information, visit www.kauffman.org, and follow the Foundation on Twitter at @kauffmanfdn and Facebook.

Click here to see all recent news from this company

LAS VEGAS, NV–(Marketwire – October 4, 2010) –  MedEx, Inc. (PINKSHEETS: MDXX) is pleased to announce a shareholder update in light of missing the date of the previously announced audit. Because of the unique position that MedEx is in with its clients, namely Medicare, Medicaid, Workman’s Compensation, and various Insurance companies, it was in a position to conduct an audit that includes the month of September, which allowed the company to complete its 3^rd quarter numbers. The audit will be released as soon as it is verified and signed off by management and the accounting firm.

“With September being particularly strong, we are excited to be able to include these numbers in our audit,” said Mr. Paul Protzman, President of MedEx, Inc.

“We would like to thank all of our existing shareholders for their patience. It is our goal to be as transparent as possible and we look forward to completing this milestone of becoming a fully reporting company. The company is currently negotiating with a number of potential acquisitions and it is important that we are current with our financials to assist in a smooth transition as we look to continue to acquire companies that we feel bring synergies to our core goal. That is to consolidate a number of DMEs (durable medical equipment) companies that are all in good standing with Medicare, Medicaid, Workman’s Comp. etc. and any other like businesses.”

About MedEx, Inc.

MedEx, Inc. is a development stage Nevada-based medical support services company, which plans to grow through acquisitions of medical supply companies, medical technology companies, and assisted living and care facilities worldwide. For additional information, see www.medexsynergies.com.  

Safe Harbor Statement:

This release contains “forward-looking statement” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may,” “future,” “plan,” or “planned,” “will,” or “should,” “expected,” “anticipates,” “draft,” “eventually,” or “projected.” You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.

AUSTIN, TX–(Marketwire – October 1, 2010) –
El sábado, 2 de octubre, se realizarán más de 1.000 eventos en todo el mundo para marcar el Día LIVESTRONG, el día mundial anual de acción para celebrar la sobrevivencia y los esfuerzos hacia un mundo sin cáncer.

El 2 de octubre también marca el décimo cuarto aniversario del diagnóstico de cáncer y el inicio de su vida como defensor del cáncer del LIVESTRONG fundador y presidente, sobreviviente de cáncer y campeón de ciclismo, Lance Armstrong.

“La lucha contra el cáncer no sucede en un laboratorio”, dijo Armstrong. “Se lleva a cabo en nuestros hogares y comunidades mientras las familias luchan por combatir esta enfermedad. Este año, el cáncer se proyecta como la principal causa de muerte, cobrando más de ocho millones de vidas. El Día LIVESTRONG, las comunidades en todo el mundo se unirán para apoyar a las personas que viven con cáncer y hacer un llamado de acción renovada de nuestros líderes para combatir esta crisis de salud mundial”.

Más de 1.000 eventos, desde paseos en bicicleta a iniciativas ?Use Amarillo”, a venta de pasteles y galletas horneadas y mucho más, tendrán lugar en los 50 estados de Estados Unidos y en 57 países el Día LIVESTRONG mientras las personas y las comunidades se mantienen unidas en solidaridad para crear mayor conciencia y recaudar fondos para la lucha contra el cáncer. Los eventos incluyen:

• Una vigilia con barras luminosas en las escalinatas el Capitolio de Colorado en Denver donde los seguidores celebrarán la supervivencia y recordaran a sus seres queridos ya perdidos
• Un evento de paseo en bicicleta y concienciación del cáncer en Boston donde los participantes pedalearán en pos de la lucha contra el cáncer
• Un evento de ciclismo de 24 horas en Atlanta donde los ciclistas recaudarán fondos para programas e investigaciones de cáncer
• Una fiesta para ver un partido de futbol de Texas/Oklahoma en la sede de LIVESTRONG en Austin donde el equipo de LIVESTRONG educará a la comunidad acerca de sus recursos
• Un evento para crear mayor conciencia y de aprendizaje en una escuela primaria en Los Ángeles donde los niños escribirán con tiza en el parque de juegos y compartirán sus ideas sobre lo significa vivir fuerte

LIVESTRONG también se asoció con Nike para crear mayor conciencia acerca del cáncer en el juego de fútbol de Red River Rivalry en Dallas entre The University of Texas en Austin versus The University of Oklahoma. Los aficionados realizarán una cartomagia centrada en el cáncer patrocinada por Nike durante el juego. La cartomagia creará una experiencia memorable para los aficionados y ayudarán a unirlos en la lucha contra el cáncer.

LIVESTRONG y RadioShack crean aún mayor conciencia sobre el cáncer el Día LIVESTRONG reclutando la ayuda de los defensores a través de Facebook y Twitter. El 2 de octubre, por cada persona que añada el número “28” a sus fotos de perfil en Facebook y Twitter para apoyar a los 28 millones de sobrevivientes de cáncer en todo el mundo, RadioShack donará $1 a LIVESTRONG hasta $100,000.

RadioShack también revelará una versión digital gigante del “Mosaico Equipo 28” en Times Square de Nueva York el Día LIVESTRONG por un solo día. El mosaico se basa en la fotografía icónica de Lance tomada en la etapa final de su Gira por Francia en 2010. El Mosaico Equipo 28 está compuesto por fotos de todos los seguidores de Facebook y Twitter que marcaron sus fotos de perfil con el símbolo del Equipo 28 (ver #team28 o http://twb.ly/team-28 vía Twitter). El vídeo de la pancarta de Military Island de Times Square se transmitirá en vivo online durante el día en http://team28.RadioShack.com, permitiendo que los seguidores vean sus imágenes de perfil agrandadas en el mosaico digital mientras las añaden.

También se motiva a los seguidores que usen Amarillo, el símbolo universalmente reconocido de la lucha contra el cáncer, Lance el Día LIVESTRONG se unirá en un testimonio mundial de fortaleza y coraje y demostrará su apoyo a los sobrevivientes de cáncer en todo el mundo. Más de 7.000 personas ya se han comprometido a usar Amarillo el Día LIVESTRONG.

El impacto del cáncer en todo el mundo aumenta todos los días. La American Cancer Society y LIVESTRONG recientemente unieron fuerzas para divulgar el primer estudio único en su tipo sobre el costo económico de todas las causas de muerte en el mundo, incluyendo el cáncer y otras enfermedades no contagiosas y contagiosas. Los datos de este estudio revelaron que el cáncer tiene el impacto económico más devastador que cualquier otra causa de muerte en el mundo, con un costo para la economía mundial de cerca de un billón de dólares al año.

El Día LIVESTRONG es una oportunidad para las personas de todo estrato social para luchar por el objetivo en común de asegurar que los sobrevivientes de cáncer en todo el mundo tengan la información, los recursos y el apoyo que necesitan para vivir con fortaleza y dignidad.

“Hoy tenemos una poderosa oportunidad para cambiar la manera en que las personas piensan acerca del cáncer”, dijo Doug Ulman, presidente y CEO de LIVESTRONG . “Toda persona que se une en la lucha contra el cáncer nos acerca hacia nuestro objetivo de un mundo libre de la enfermedad”.

To learn more, visit www.LIVESTRONG.org.

Acerca de LIVESTRONG
LIVESTRONG, fundada en 1997 por el sobreviviente de cáncer y campeón de ciclismo Lance Armstrong y centralizada en Austin, Texas, lucha por los 28 millones de personas en todo el mundo que viven con cáncer hoy en día. LIVESTRONG conecta a las personas con el apoyo que necesitan, utiliza fondos y recursos para estimular la innovación y compromete a las comunidades y líderes para impulsar un cambio social. Conocida por su icónica banda amarilla, la misión de LIVESTRONG es inspirar y empoderar a cualquier persona afectada por el cáncer.

AUSTIN, TX–(Marketwire – October 1, 2010) –
Sábado, dia 2 de outubro, mais de 1.000 eventos em todo o mundo serão realizados para marcar o Dia LIVESTRONG, o dia anual mundial de ação para comemorar a sobrevivência e trabalho em prol de um mundo sem câncer.

O dia 2 de outubro também é o aniversário de 14 anos do diagnóstico e câncer do sobrevivente de câncer e ciclista camprão Lance Armstrong, fundador e chairman do LIVESTRONG e do início da sua vida como lutador contra o câncer.

“A luta contra o câncer não acontece em um laboratório”, disse Armstrong. “Ela acontece nas nossas casas e comunidades com a luta das famílias para vencer esta doença. Este ano, o câncer deve ser a principal causa de mortes, ceifando mais de oito milhões de vidas. No Dia LIVESTRONG, as comunidades de todo o mundo se unirão para dar suporte para quem vive com câncer pedindo ação renovada dos nossos líderes para o combate a esta crise de saúde mundial”.

Mais de 1.000 eventos — passeios de bicicleta, iniciativas “Wear Yellow” (usem amarelho), vendas de doces e outras — serão realizados nos 50 estados dos EUA e em 57 países no Dia LIVESTRONG com as pessoas e as comunidades se unindo em solidariedade para disseminar o conhecimento da luta contra o câncer. Os eventos são:

• Uma vigília com uma haste brilhante nas escadas do Capitólio de Colorado em Denver para comemorar a sobrevivência e lembrar a perda de entes queridos.
• Um passeio de bicicleta em grupo e um evento de informação sobre o câncer em Boston onde os participantes irão pedalar para lutar contra o câncer.
• Um evento de ciclismo de 24 horas em Atlanta onde os ciclistas angariarão fundos para programas e pesquisa sobre o câncer.
• Uma festa para assistir o jogo de futebol americano do Texas/Oklahoma na sede da LIVESTRONG em Austin onde a equipe da LIVESTRONG irá informar a comunidade sobre os seus recursos.
• Um evento de aprendizado e disseminação de informação em uma escola de ensino fundamental em Los Angeles onde as crianças desenharão com giz no chão do playground e compartilhar suas ideias sobre o que elas acham ser ter uma vida forte.

LIVESTRONG também fez uma parceria com a Nike para disseminar o conhecimento do câncer em um jogo de futebol americano Red River Rivalry em Dallas da University of Texas at Austin e The University of Oklahoma. Os fãs farão uma apresentação com quadros sobre o câncer patrocinada pela Nike durante o jogo. A apresentação será uma experiência memorável para os fãs e irá ajudá-los na luta contra o câncer.

LIVESTRONG e RadioShack irão disseminar ainda mais o conhecimento sobre o câncer no Dia LIVESTRONG ao solicitar a ajuda de simpatizantes no Facebook e Twitter. No dia 2 de outubro, para cada pessoa que adicionar o número “28” nas fotos dos seus perfis no Facebook e Twitter em apoio aos 28 milhões de sobreviventes de câncer em todo o mundo, o RadioShack fará uma doaç ao de $1 dólar para LIVESTRONG com um máximo de $100.000,00.

RadioShack também fará uma apresentação digital do “Team 28 Mosaic” (Mosaico do número 28 da equipe) na Times Square de Nova York sobre o Dia LIVESTRONG apenas um dia. O mosaico está baseado na fotografia icônica de Lance tirada na etapa final da Tour de France de 2010. O Team 28 Mosaic é composto de fotos de todos os simpatizantes do Facebook e do Twitter que incluíram nas fotos do seu perfil o símbolo Team 28 (veja #team28 ou http://twb.ly/team-28 no Twitter). O vídeo do outdoor da Ilha Militar da Times Square será transmitido online ao vivo durante o dia no http://team28.RadioShack.com, para que os simpatizantes possam ver as imagens gigantescas dos perfis no mosaico digital à medida que são adicionadas.

Os simpatizantes também devem usar amarelho, o símbolo reconhecido mundialmente da luta contra o câncer, juntamente com Lance no Dia LIVESTRONG em uma demonstração mundial de força e coragem em apoio aos sobreviventes do câncer em todo o mundo. Mais de 7.000 pessoas já se comprometeram a usar amarelo no Dia LIVESTRONG.

O impacto do câncer em todo o mundo continua a aumentar diariamente. A American Cancer Society e LIVESTRONG recentemente se uniram para publicar o primeiro estudo sobre o custo econômico de todas as causas da morte no mundo, incluindo o câncer e outras doenças comunicáveis e não comunicáveis. Os dados deste estudo mostram que o câncer tem o impacto mais devastador do que qualquer causa de morte no mundo, custando quase três milhões de dólares ao ano para a economia global.

O Dia LIVESTRONG é uma oportunidade para as pessoas de todas as áreas trabalharem em prol de um objetivo comum de garantir que os sobrevivente do câncer de todo o mundo tenham acesso à informação, recursos e suporte necessários para que elas possam viver a vida com forá e dignidade.

“Hoje, temos a grande oportunidade de mudar a forma como as pessoas pensam sobre o câncer”, disse Doug Ulman, Presidente e CEO da LIVESTRONG. “Cada indivíduo que se úne à luta contra o câncer nos leva cada vez mais próximos ao nosso objetivo de um mundo sem esta doença”.

Para mais informações, acesse www.LIVESTRONG.org.

LIVESTRONG
Fundada em 1997 pelo sobrevivente de câncer e campeão de ciclismo Lance Armstrong e baseada em Austin, Texas, a LIVESTRONG luta pelas 28 milhões de pessoas que vivem com câncer no mundo todo hoje. A LIVESTRONG conecta indivíduos para atender suas necessidades, aproveitar os financiamentos e recursos para impulsionar a inovação e envolver as comunidades e líderes na mudança social. Conhecida por sua pulseira amarela icônica, a LIVESTRONG tem por missão inspirar e capacitar qualquer pessoa afetada pelo câncer.

WICHITA, KS–(Marketwire – October 1, 2010) –  Pulse Systems, Inc. announced today that 2011 Pulse Complete EHR, Version 2011, is 2011/2012 compliant and was certified as a Complete EHR on September 30, 2010 by the Certification Commission for Health Information Technology (CCHIT®), an ONC-ATCB, in accordance with the applicable eligible provider certification criteria adopted by the Secretary of Health and Human Services. The 2011/2012 criteria support the Stage 1 meaningful use measures required to qualify eligible providers and hospitals for funding under the American Recovery and Reinvestment Act (ARRA).

“I am certain our clients will be at the front of the line when the incentive payments begin in April 2011 — the first of five payments totaling up to $44,000. This is because our EHR product is in the first group to receive this landmark certification. This mirrors our industry-leading accomplishment in being the first to receive the full comprehensive CCHIT 2011 certification in December of 2009,” said Basil Hourani, President and CEO of Pulse Systems. 

“We built our EHR software with the capability to be used in a meaningful way to help our clients provide more efficient patient care before that concept was even legislated,” he said. “This foresight is the primary reason that we were able to receive certification so promptly.”

The ONC-ATCB 2011/2012 certification program tests and certifies that Complete EHRs meet all of the 2011/2012 criteria and EHR Modules meet one or more — but not all — of the criteria approved by the Secretary of Health and Human Services (HHS) for either eligible provider or hospital technology.

“CCHIT is pleased to be testing and certifying products so that companies are now able to offer these products to providers who wish to purchase and implement certified EHR technology and achieve meaningful use in time for the 2011-2012 incentives,” said Karen M. Bell, M.D., M.S.S., Chair, CCHIT.

2011/2012 certification conferred by CCHIT does not represent an endorsement of the certified EHR technology by the U.S. Department of Health and Human Services nor does it guarantee the receipt of incentive payments.

The clinical quality measures to which 2011 Pulse Complete EHR has been certified include:

2011 Pulse Complete EHR version 2011 is also certified in CCHIT’s separate and independently developed certification program. 2011 Pulse Complete EHR version 2011 is a CCHIT Certified® 2011 Ambulatory EHR, additionally certified for Child Health. Pulse Systems has certified its EHR technology in both programs to provide greater assurance to its customers.

About Pulse Systems, Inc.
Pulse offers Electronic Health Records (EHR), Practice Management, ePrescribing and Revenue Cycle Management (Billing Services) used nationwide in more than 26 medical specialties. Pulse Practice Management and EHR products have both earned five star ratings from AC Group. Since 1982 Pulse has developed, marketed and supported healthcare practice workflow solutions that are easier to purchase, implement, learn, utilize and upgrade. This focus on making things easier for clients is the key to a remarkable 95% client renewal rate. Pulse is a part of Cegedim Healthcare Software (CHS), a division of $1.1 billion global healthcare technology company Cegedim Group. For more information, please visit www.pulseinc.com.

About CCHIT
The Certification Commission for Health Information Technology (CCHIT®) is an independent, 501(c)3 nonprofit organization with the public mission of accelerating the adoption of robust, interoperable health information technology. The Commission has been certifying electronic health record technology since 2006 and is approved by the Office of the National Coordinator for Health Information Technology (ONC) of the U.S. Department of Health and Human Services (HHS) as an Authorized Testing and Certification Body (ONC-ATCB). More information on CCHIT, CCHIT Certified® products and ONC-ATCB certified electronic health record technology is available at http://cchit.org.

About ONC-ATCB 2011/2012 certification
The ONC-ATCB 2011/2012 certification program tests and certifies that EHR technology is capable of meeting the 2011/2012 criteria approved by the Secretary of Health and Human Services (HHS). The certifications include Complete EHRs, which meet all of the 2011/2012 criteria for either eligible provider or hospital technology and EHR Modules, which meet one or more — but not all — of the criteria. ONC-ATCB certification aligns with Health Information Technology: Initial Set of Standards, Implementation Specifications, and Certification Criteria for Electronic Health Record Technology published in the Federal Register in July 2010 and strictly adheres to the test procedures published by the National Institute of Standards and Technology (NIST) at the time of testing. ONC-ATCB 2011/2012 certification conferred by the Certification Commission for Health Information Technology (CCHIT®) does not represent an endorsement of the certified EHR technology by the U.S. Department of Health and Human Services nor does it guarantee the receipt of incentive payments.

“CCHIT®” and “CCHIT Certified®” are registered trademarks of the Certification Commission for Health Information Technology.

Click here to see all recent news from this company

SUNRISE, FL–(Marketwire – October 1, 2010) –  Interim HealthCare® Inc., the nation’s first and finest healthcare and in-home senior care franchise company, is donating in-home, non-medical care to the Lutz family of East Setauket, NY, in the Town of Brookhaven, as part of the October 3^rd episode of ABC’s Emmy-winning hit show Extreme Makeover: Home Edition. The local Interim HealthCare in New York, owned and operated by Jim Watson, is providing the family’s six young adult children, all of whom have Down syndrome, with a staff member to assist with companionship and homemaker care. The in-kind donation totals 20 hours per week for a year.

“Interim HealthCare became aware of the needs of the Lutz family several months ago, and as an in-home care company specializing in services the Lutz family needed, we felt compelled to help,” said Jim Watson, owner of Interim HealthCare of Greater New York. “We know firsthand the struggles that families encounter when they are the primary caregivers for their relatives, and we knew Interim HealthCare could certainly be of assistance in this case.”

Unable to have any children of their own, Grace and John Lutz gave their hearts to 18 adopted children, including seven with Down syndrome. After the couple unexpectedly passed away, their daughter Kathleen, gladly gave up her career and came home to take care of her six Down syndrome siblings who currently range in age from 20 to 25 years old. Everyone agreed that putting the kids in a group home or institution was not an option. It was a good plan, until Kathleen unexpectedly had a grand mal seizure and was diagnosed with inoperable cancer. Her brother John Jr., was next to help, sacrificing his career as a gymnastics coach to move home and care for his sister and other siblings. Kathleen’s health is now stabilized and both brother and sister care for their family as a team.

For more information about Interim HealthCare in Stony Brook, NY please contact Ellen Hamburger, Branch Administer at 631-689-8920. The local office is open from 8:00 am – 5:00 pm Monday – Friday, and can be reached 24 hours a day, seven days a week.

About Interim HealthCare:
Founded in 1966, Interim HealthCare® is the nation’s oldest proprietary national health care franchise organization providing health care personnel at all skill levels in all settings. Through a comprehensive network of more than 300 independently owned franchise offices, Interim HealthCare® franchisees are the largest combined provider of community-based home care (skilled and non-medical) and health care staffing. Interim HealthCare is unique in combining the commitment of local ownership with the support of a national organization that develops innovative programs and quality standards that improve the delivery of service through franchisees who employ more than 75,000 health care workers who serve 50,000 people each day. For more information or to locate an Interim HealthCare office, visit www.interimhealthcare.com.

About Extreme Makeover: Home Edition
The Emmy award winning reality program “Extreme Makeover: Home Edition,” is entering its 7th season, is produced by Endemol USA, a division of Endemol Holding. It’s executive-produced by Brady Connell and George Verschoor. David Goldberg is Chairman, Endemol North America. The show airs Sundays from 8:00-9:00 p.m., ET on ABC.

Click here to see all recent news from this company

AUSTIN, TX–(Marketwire – October 1, 2010) –  On Saturday, October 2nd, more than 1,000 events throughout the world will take place to mark LIVESTRONG Day, the annual global day of action to celebrate survivorship and work toward a world without cancer.

October 2 also marks the 14^th anniversary of LIVESTRONG founder and chairman, cancer survivor and champion cyclist Lance Armstrong’s cancer diagnosis and the beginning of his life as a cancer advocate.

“The fight against cancer doesn’t happen in a lab,” said Armstrong. “It takes place in our homes and communities as families struggle to beat this disease. This year, cancer is projected to become the world’s leading cause of death, claiming more than eight million lives. On LIVESTRONG Day, communities throughout the world will unite to support those living with cancer and call for renewed action by our leaders to combat this global health crisis.” 

More than 1,000 events — from bike rides and “Wear Yellow” initiatives, to bake sales and beyond — will take place in all 50 U.S. states and across 57 countries on LIVESTRONG Day as individuals and communities stand unified in solidarity to raise awareness and funds for the fight against cancer. Events include:

• A glow stick vigil on the Colorado Capitol steps in Denver where supporters will celebrate survivorship and remember lost loved ones
• A group bike ride and cancer awareness event in Boston where participants will pedal to fight cancer
• A 24-hour cycling event in Atlanta where cyclists will raise funds for cancer programs and research
• A Texas/Oklahoma football game watching party at LIVESTRONG headquarters in Austin where LIVESTRONG staff will educate the community about its resources
• A learning and awareness building event at an elementary school in Los Angeles where children will chalk up the playground and share their ideas about what it means to live strong

LIVESTRONG has also partnered with Nike to raise cancer awareness at the Red River Rivalry football game in Dallas featuring The University of Texas at Austin versus The University of Oklahoma. Fans will perform a cancer-focused card stunt sponsored by Nike during the game. The stunt will create a memorable experience for fans and help unite them in the fight against cancer.

LIVESTRONG and RadioShack are further raising cancer awareness on LIVESTRONG Day by enlisting the help of supporters through Facebook and Twitter. On October 2, for every person who adds the number “28” to their Facebook and Twitter profile pictures to support the 28 million cancer survivors around the world, RadioShack will donate $1 to LIVESTRONG up to $100,000.

RadioShack will also unveil a giant digital rendition of the “Team 28 Mosaic” in New York’s Times Square on LIVESTRONG Day for one day only. The mosaic is based on the iconic photograph of Lance taken at the final stage of the 2010 Tour de France. The Team 28 Mosaic is comprised of photos of all the Facebook and Twitter supporters who have tagged their profile photos with the Team 28 symbol (see #team28 or http://twb.ly/team-28 via Twitter). Video of the billboard at Times Square’s Military Island will be streamed live online during the day at http://team28.RadioShack.com, allowing supporters to view larger-than-life profile images on the digital mosaic as they are added.

Supporters are also encouraged to wear yellow, the universally recognized symbol of the fight against cancer, with Lance on LIVESTRONG Day to join in a global statement of strength and courage and show support for cancer survivors around the world. More than 7,000 people have already committed to wearing yellow on LIVESTRONG Day.

The impact of cancer around the globe is growing every day. The American Cancer Society and LIVESTRONG recently joined together to release a first-of-its-kind study on the economic cost of all causes of death globally, including cancer and other noncommunicable diseases and communicable diseases. The data from this study revealed that cancer has the most devastating economic impact of any cause of death in the world, costing the global economy nearly a trillion dollars a year.

LIVESTRONG Day is an opportunity for people from all walks of life to work toward the common goal of ensuring that cancer survivors around the world have the information, resources and support they need to live with strength and dignity.

“Today we have a powerful opportunity to change the way people think about cancer,” said Doug Ulman, LIVESTRONG President and CEO. “Every single person who joins the fight against cancer brings us closer to our goal of a world free from the disease.”

To learn more, visit www.LIVESTRONG.org.

About LIVESTRONG
Founded in 1997 by cancer survivor and champion cyclist Lance Armstrong and based in Austin, Texas, LIVESTRONG fights for the 28 million people around the world living with cancer today. LIVESTRONG connects individuals to the support they need, leverages funding and resources to spur innovation and engages communities and leaders to drive social change. Known for the iconic yellow wristband, LIVESTRONG‘s mission is to inspire and empower anyone affected by cancer.

NEW YORK, NY–(Marketwire – October 1, 2010) –  Hearst Corporation announced today that Gregory H. Dorn, MD, MPH, has been named president of First DataBank, a subsidiary of Hearst Business Media. Dorn succeeds Donald M. Nielsen, MD, who has been appointed chairman of the First DataBank Advisory Board and senior health advisor. The appointments were announced today by Frank A. Bennack, Jr., vice chairman and CEO of Hearst Corporation, and Richard P. Malloch, president of Hearst Business Media, and are effective immediately.

Most recently, Dorn was executive vice president of Zynx Health, another Hearst health-care property. In this management position, Dorn focused on point-of-care clinical decision support solutions. Zynx Health has grown under Hearst’s ownership to serve more than 1,700 hospitals in the U.S.

“Over the past six years, Greg has contributed to Zynx’s extraordinary success and expansion, which has resulted in revenue growth each year of about 70 percent,” Malloch said. “In the coming years, with the growing adoption of electronic health records and e-prescribing, we see First DataBank as well poised for significant growth, and Greg is the right leader to see that through.”

Dorn has numerous peer-reviewed publications and is co-author of a pending patent and a lecturer on quality improvement for the UCLA Center for Health Services Management. He has a bachelor’s degree from the Columbia University School of Engineering and received his medical doctorate from the College of Physicians and Surgeons at Columbia University. Dorn served as house officer at UCLA Medical Center after which he went on to obtain his master’s in health services from the UCLA Center for Health Services Management. Dorn will be based out of First DataBank’s offices in San Francisco.

In his new role as chairman of the First DataBank Advisory Board, Nielsen will focus on strengthening First DataBank’s long-standing commitment to patient safety and health-care data quality issues. Nielsen also will be working on initiatives related to drug reimbursement.

“Don has done an outstanding job driving First DataBank’s leadership position in patient safety and health care quality during the past four years,” Malloch said. “I’m thrilled to have Don now leading two very important areas at First DataBank. There is no one as well qualified as Don to advocate for quality in data and patient care and his extensive knowledge and understanding of drug reimbursement practices will be of great value to Hearst as a whole as we build out those areas of business.”

About First DataBank
First DataBank, a subsidiary of Hearst Corporation, drives patient safety and health care quality by providing drug databases that are used within information systems that touch every aspect of health care. For 30 years, First DataBank has partnered with system developers to integrate and optimize its drug information to improve user workflow and enhance clinical decision-making by those entrusted with treating patients at the point-of-need. Together with its development partners, First DataBank helps reduce the incidence of medication errors and adverse drug events, which promises to lower health-care costs and improve patient care. For more information about First DataBank, call 800-633-3453 or visit www.firstdatabank.com.

About Hearst Corporation
Hearst Corporation (www.hearst.com) is one of the nation’s largest diversified media companies. Its major interests include ownership of 15 daily and 38 weekly newspapers, including the Houston Chronicle, San Francisco Chronicle, San Antonio Express-News and Albany Times Union; nearly 200 magazines around the world, including Good Housekeeping, Cosmopolitan and O, The Oprah Magazine; 29 television stations, which reach a combined 18% of U.S. viewers; ownership in leading cable networks, including Lifetime, A&E, History and ESPN; as well as business publishing, including a minority joint venture interest in Fitch Ratings; Internet and marketing services businesses, television production, newspaper features distribution and real estate.

id=”nav_links”>

NEWPORT BEACH, CA–(Marketwire – October 1, 2010) –  NVISION Laser Eye Centers, formerly part of TLC Laser Eye Centers, announced today that Dr. Tom Tooma has been selected by Goldline Research as one of the leading Laser Eye Surgeons of the United States for 2010. The list of leading Laser Eye Surgeons of the United States was published this week in Forbes Magazine.

“It is a great honor to be selected by Goldline Research and to receive this distinction as one of only ten LASIK surgeons to be listed in Forbes Magazine in 2010,” said Dr. Tom Tooma, the Medical Director for NVISION Laser Eye Centers, formerly part of TLC Laser Eye Centers, and renowned eye surgeon who has performed more than 100,000 vision correction procedures.

“There are more than 10,000 laser eye surgeons in the United States. The practices that we selected provide outstanding patient care that exceeds the industry standard,” said Victoria Coryelle, Analyst, Goldline Research. “We believe that these practices are setting the benchmarks for patient service for the industry as a whole.”

Goldline Research, an independent, third-party research firm specializing in evaluating special services firms, undertook an extensive research process, including individual company interviews, qualitative analysis of company data and customer reference checks to determine high-quality patient care. Dr. Tom Tooma, NVISION Laser Eye Centers, was the only practice chosen in California due to his remarkable service and overall patient satisfaction in the industry.

About NVISION Laser Eye Centers
NVISION Laser Eye Centers, formerly part of TLC Laser Eye Centers, has eight locations throughout Southern California from San Diego to Camarillo. With more than 1,300 eye doctors who refer their patients and trust their own eyes to NVISION affiliate surgeons, we are the Eye Doctors’ #1 Choice, and serve the counties of San Diego, Los Angeles, Orange, Riverside, Ventura and San Bernardino. For more information, visit our new web site at www.NVISIONCenters.com or call 1-877-91NVISION (1-877-916-8474).

Click here to see all recent news from this company

SILVER SPRING, MD–(Marketwire – October 1, 2010) –  The Association of Public Health Laboratories (APHL) is proud to announce the dedication of the new comprehensive New Mexico public health laboratory. On September 29, 2010, the New Mexico Scientific Laboratory Division dedicated their beautiful, state-of-the-art facility which will double their space and greatly expand testing capabilities.

“This new laboratory is the crown jewel of state government,” said Arturo L. Jaramillo, cabinet secretary of the New Mexico General Services Department.

A LEED-certified green facility, this cutting edge laboratory boasts accreditations by numerous agencies. For the first time, the New Mexico public health laboratory will have onsite training facilities. Agreements have already been finalized with the Centers for Disease Control and Prevention to do Laboratory Response Network (LRN) training, the Food and Drug Administration for their dairy analyst training, and the University of New Mexico law school to teach new judges the scientific methods of DWI testing.

“It takes a special laboratory to help shape the future — a specially equipped facility staffed with highly qualified and trained experts, one like the laboratory here,” said APHL’s Executive Director, Scott Becker who attended the dedication. “Who knows — this new space could uncover the clues of some of our most pressing public health issues.”

This year marks the 90th anniversary of the New Mexico public health laboratory. From its origin in 1920 with one visionary employee in a one-room facility, the new building will house state-of-the-art clinical, environmental and forensic analytical services in support of public health across the state and nation.

Press tours of the new public health laboratory will take place on Friday, October 1, 2010.

The Association of Public Health Laboratories is a national non-profit located in Silver Spring, MD, that is dedicated to working with members to strengthen governmental laboratories with a public health mandate. By promoting effective programs and public policy, APHL strives to provide public health laboratories with the resources and infrastructure needed to protect the health of US residents and to prevent and control disease globally.

Click here to see all recent news from this company

LOUISVILLE, CO–(Marketwire – October 1, 2010) –  GlobeImmune Inc. today announced that an abstract related to GI-5005, its Phase 2 investigational hepatitis C virus (HCV) product candidate, has been accepted for a late breaking oral presentation at the 61^st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), which will take place October 29 through November 2, 2010, in Boston.

At the AASLD annual meeting, GlobeImmune will present end-of-study data, including sustained virologic response (SVR) rate from prior non-responders, from a Phase 2 clinical study investigating the safety and efficacy of GI-5005. The study compared GI-5005 plus peg-interferon (peg-IFN) and ribavirin, the current standard of care (SOC), versus SOC alone in patients with chronic type 1 hepatitis C infection. Prior non-responders were defined as those patients who did not achieve viral negativity by PCR after a minimum of 12 weeks of SOC. Patients that had achieved viral negativity by PCR during prior SOC but had relapsed during or after completion of SOC therapy were excluded from the study.

The abstract, titled “GI-5005 Therapeutic Vaccine Plus PEG-IFN/Ribavirin Improves Sustained Virologic Response Versus PEG-INF/Ribavirin in Prior Non-Responders With Genotype 1 Chronic HCV Infection,” is published online at the AASLD Web site.

Dr. Paul J. Pockros of Scripps Clinic is the lead author of the abstract that will be presented as part of a late breaker oral session beginning at 6 p.m. EDT on Monday, November 1, 2010 in the Hynes Auditorium. The presentation will include complete response and sustained virologic response rates for patients who received the GI-5005 plus SOC as well as SOC patients in the control arm of the study.

Additionally, Dr. John M. Vierling of Baylor College of Medicine will present a poster titled “GI-5005 Therapeutic Vaccine Improves Deficit in Cellular Immunity in IL28B Genotype T/T, Treatment-Naïve Patients with Chronic Hepatitis C Genotype 1 When Added to Standard of Care PEG-IFN-Alfa-2A/Ribavirin,” on Tuesday, November 2, 2010 in the Hynes Exhibit Hall C.

GI-5005 is a therapeutic vaccine candidate that the company believes generates HCV specific T-cell responses and improves virologic responses in patients with chronic hepatitis C infection. 

About GlobeImmune
GlobeImmune Inc. is a private company developing active immunotherapies called Tarmogens for the treatment of cancer and infectious diseases. Tarmogens generate activated killer T cells that are designed to locate and eliminate cancer cells and/or virally-infected cells. The Company’s lead product candidate, GI-5005, is a Tarmogen being developed for the treatment of chronic hepatitis C infection (HCV). GI-5005 is designed to complement both the current standard of care and emerging novel therapies for HCV. The Company’s lead oncology program, GI-4000, targets cancers caused by mutated versions of the Ras oncoprotein. GI-4000 is being investigated in clinical trials for the treatment of pancreas cancer as well as other cancers that contain mutated Ras, including non-small cell lung cancer and colorectal cancer. In May 2009, the Company announced a global partnership with Celgene focused on the discovery, development and commercialization of multiple product candidates for the treatment of cancer.

For additional information, please visit the company’s Web site at www.globeimmune.com.

This news release and the anticipated presentation contain forward-looking statements that involve risks and uncertainties, including statements relating to initiation and progress of the Company’s clinical trial programs and the results from the clinical trials. Actual results could differ materially from those projected and the Company cautions readers not to place undue reliance on the forward-looking statements contained in the release and anticipated presentation.

SPRINGFIELD, OH–(Marketwire – October 1, 2010) –  AdCare Health Systems, Inc. (NYSE Amex: ADK), a recognized innovator in senior living and health care facility management, has closed the previously announced purchase agreement for two privately-held nursing homes in Gladsden, Alabama for $18.5 million.

The two facilities have a total of 306 beds, which currently generate about $18 million in annualized revenue and are expected to be immediately accretive to earnings. Combined with other transactions closed earlier in the year, AdCare’s estimated annualized revenue run-rate now exceeds $96 million, which represents an increase of approximately 261% from $26.7 million in the year ended 2009.

AdCare financed this purchase through a local bank, with a guarantee by the United States Department of Agriculture (USDA). The guarantee is provided through a program developed by the government to supply long-term financing for rural projects at favorable rates.

“This transaction is the fourth we’ve closed since we began our M&A campaign at the end of last year,” said Chris Brogdon, AdCare’s vice chairman and chief acquisitions officer. “We expect all of our new facilities to be significant cash generators for AdCare, especially as they come under our highly capable management and benefit from our larger economy of scale.”

“As we move toward closing the remaining transactions we announced, additional opportunities continue to emerge in the southern region of the U.S. as well as in the Midwest,” said Brogdon. “We are working to establish the terms and necessary financings for several new potential acquisitions in our pipeline of equal or greater potential.”

Brogdon joined AdCare in September 2009 when the company announced a new M&A growth strategy to build upon its strong reputation for operational efficiency and high-quality living environments.

About AdCare Health Systems
AdCare Health Systems, Inc. (NYSE Amex: ADK) is a recognized innovator in senior living and health care facility management. AdCare develops, owns and manages assisted living facilities, nursing homes and retirement communities, as well as provides home health care services. Since its inception in 1988, AdCare’s mission has been to provide the highest quality of healthcare services to the elderly. For more information about AdCare, visit www.adcarehealth.com.

Important Cautions Regarding Forward-Looking Statements
Statements contained in this press release that are not historical facts may be forward-looking statements within the meaning of federal law. Such statement can be identified by the use of forward-looking terminology, such as “believes,” “expects,” “plans,” “intends,” “anticipates” and variations of such words or similar expressions, but their absence does not mean that the statement is not forward-looking. Statements in this announcement that are forward-looking include, but are not limited to, statements that the company expects all of these new facilities to be significant cash generators for AdCare. Such forward-looking statements reflect management’s beliefs and assumptions and are based on information currently available to management. The forward-looking statements involve known and unknown risks, results, performance or achievements of the Company to differ materially from those expressed or implied in such statements. Such factors are identified in the public filings made by the Company with the Securities and Exchange Commission and include the Company’s ability to secure lines of credit and/or an acquisition credit facility, find suitable acquisition properties at favorable terms, changes in the health care industry because of political and economic influences, changes in regulations governing the industry, changes in reimbursement levels including those under the Medicare and Medicaid programs and changes in the competitive marketplace. There can be no assurance that such factors or other factors will not affect the accuracy of such forward-looking statements.

Click here to see all recent news from this company

METHUEN, MA–(Marketwire – September 30, 2010) –  A ribbon cutting event is occurring at Suntron Corporation’s new manufacturing facility. Join Ed Wheeler, CEO of Suntron; Lt. Governor Timothy P. Murray; Congresswomen Niki Tsongas; Mayor Manzi III and Jose Bevilacqua in the opening event at 1pm, facility tour to follow.

MENOMONEE FALLS, WI–(Marketwire – September 30, 2010) – Assisted Living Concepts, Inc. (“ALC”) (NYSE: ALC) announces the expansion and extension of a loan agreement with TCF National Bank (“TCF”). The revised loan agreement increases the loan from $14.0 million to $26.25 million and extends the maturity from June 12, 2014 to September 30, 2015. The loan bears interest at the rate of 6.5% and is secured by mortgages on six of ALC’s senior housing residences.

“We are pleased to have completed a second round of financing with TCF,” commented Laurie Bebo, President and Chief Executive Officer of Assisted Living Concepts, Inc. “Appraisals on the three properties added to secure this loan were in excess of $100,000 per unit, once again demonstrating the value of our business model for owned properties. We own 46 additional unencumbered properties.” 

About Us
Assisted Living Concepts, Inc. and its subsidiaries operate 211 senior living residences comprising 9,280 residents in 20 states. ALC’s senior living facilities typically consist of 40 to 60 units and offer residents a supportive, home-like setting and assistance with the activities of daily living. ALC employs approximately 4,100 people.

Forward-looking Statements
Statements contained in this release other than statements of historical fact, including statements regarding anticipated financial performance, business strategy and management’s plans and objectives for future operations, including management’s expectations about improving occupancy and private pay mix, are forward-looking statements. Forward-looking statements generally include words such as “expect,” “point toward,” “intend,” “will,” “indicate,” “anticipate,” “believe,” “estimate,” “plan,” “strategy” or “objective.” Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. In addition to the risks and uncertainties referred to in the release, other risks and uncertainties are contained in ALC’s filings with United States Securities and Exchange Commission and include, but are not limited to, the following: changes in the health care industry in general and the senior housing industry in particular because of governmental and economic influences; changes in general economic conditions, including changes in housing markets, unemployment rates and the availability of credit at reasonable rates; changes in regulations governing the industry and ALC’s compliance with such regulations; changes in government funding levels for health care services; resident care litigation, including exposure for punitive damage claims and increased insurance costs, and other claims asserted against ALC; ALC’s ability to maintain and increase census levels; ALC’s ability to attract and retain qualified personnel; the availability and terms of capital to fund acquisitions and ALC’s capital expenditures; changes in competition; and demographic changes. Given these risks and uncertainties, readers are cautioned not to place undue reliance on ALC’s forward-looking statements. All forward-looking statements contained in this report are necessarily estimates reflecting the best judgment of the party making such statements based upon current information. ALC assumes no obligation to update any forward-looking statement.

CORAL SPRINGS, FL–(Marketwire – September 30, 2010) –  Valiant Health Care, Inc. (OTCBB: VHCI) (PINKSHEETS: VHCI) announces that it has executed a term sheet with Atlantic Medical Supply, Inc., a Florida corporation (“AMS”), under which it will acquire all of the outstanding shares of AMS in exchange for cash, shares of Valiant’s common stock and options to purchase shares of Valiant’s common stock. 

Atlantic is a Joint Commission Accredited, Medicare Certified firm serving South Florida’s home medical equipment and supply needs since 1993. As one of the area’s largest retail suppliers of home health products and services, they provide superior customer service and top quality, state-of-the-art medical equipment and supplies.

The parties intend to quickly negotiate the stock purchase agreement and hope to close the transaction as quickly as possible, but no later than six months from the signing of the term sheet. Specific terms of the purchase will be provided when the stock purchase agreement is completed and filed with the SEC as required.

Ms. Salem, Co-founder of Accessible stated that “Acquisition of Atlantic a DME provider is the next important step toward achieving our objective of being a “One Stop Provider” of home health care” she continued “We are looking forward to having the Founders of Atlantic join our team, they bring 17 years each of successful experience in the home health care industry.”

About Valiant Health Care, Inc.
Through our Accessible Home Health Care division, we offer and sell a proven one of its kind franchise opportunity to establish and operate a full service medical and personal care Accessible Home Health Care franchise, under our distinctive brand and system. As of the date of this press release, there are 96 Accessible Home Health Care franchise units and one company-owned unit in 24 states, as well as in India and Kenya.

Accessible’s business model is designed to lead and direct the 21st Century demands of the long term home health care industry by offering a “Complete Home Healthcare Package™” and being a “One Stop Provider™.” Accessible’s primary mission is to provide the highest quality home health care services and products to its patients while adding value to the payers by reducing direct costs and the potential for fraud. Accessible’s next phase of growth includes an expansion of its company owned units by acquisition of Medicare certified home health care providers in strategic geographic markets.

Forward-Looking Statements
This release is not an offer to purchase or sell securities and may contain statements that are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Certain statements herein are or may be based on current estimates and projections about Valiant’s business, which are derived in part on assumptions of its management, and are not guarantees of future performance, as such performance is difficult to predict. Valiant assumes no obligation to update information concerning its expectations.

TAMPA, FL–(Marketwire – September 30, 2010) –  eFUEL EFN, Corp. (PINKSHEETS: EFLN) is pleased to announce that Riverside Assisted Living, Inc. (RAL) and eFUEL have executed a Letter of Intent and Understanding with regard to the following:

• It is the intention of eFUEL and RAL that within forty-five (45) days of the execution of the Letter of Intent and Understanding dated September 24, 2010, that they will enter into a Stock Exchange Agreement.

• The Principles of RAL agree to cause RAL to merge into eFUEL as a wholly owned subsidiary of eFUEL.

• The sole asset of RAL at the time of the aforementioned merger will be a 244,000 square ft. mortgaged hospital building on 16 acres located in Warren, Ohio.

About eFUEL EFN, Corp.:

eFUEL EFN, Corp. (“eFUEL”) is a publicly traded company listed on Pink Sheets under the symbol EFLN. eFUEL is an internet services company offering a wide variety of products including but not limited to background screening and verification sites, including www.ValiMate.com, www.VeritasID.com, and www.FastandEasyID.com, www.BackgroundAnswers.com and also www.VerifiAmerica.com, on-line dating sites www.outRAGEousEncounters.com and www.PositiveLove.com, and recently launched a new service called Easy ID, the fastest, easiest ID verification available on the internet. This product will be offered to all new members who purchase any www.eFUELstore.com service. Simply enter a person’s full name and birthday and the background information will be provided. This service is also available at the company’s main site www.eFUELstore.com or www.ValiMate.com. For additional Product information, go to our corporate site at www.eFUELcorp.com

Safe Harbor Statement: Certain Statements in this press release constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking statements are subject to risks and uncertainties including, without limitation, changes in levels of competition, possible loss of customers, and the company’s ability to attract and retain key personnel.

BOCA RATON, FL–(Marketwire – September 30, 2010) –  XenaCare Holdings, Inc. (OTCBB: XCHO) announced today that it has signed a private label marketing agreement with Renaissance Publishing LLC covering three of its clinical supplement products.

Under the terms of the agreement XenaCare will supply Renaissance with finished product for private label marketing in the United States with packaging and branding provided by Renaissance.

Commenting on the agreement, Frank Rizzo, President and CEO of XenaCare, states, “We are very pleased to be working with Renaissance for U.S. private label marketing of these proprietary clinical supplement products. They fit into Renaissance’s growing portfolio of anti-aging dietary supplements that promote increased health, well-being, and life expectancy and allow us to concentrate our efforts and resources on Cobroxin™. We believe that the Renaissance strategy of providing education about its products along with its direct response sales model will result in greater awareness and sales of these unique products and look forward to a successful relationship with Renaissance.”

XenaCare expects to strengthen its distribution matrix for future product introductions through a strategic relationship with Renaissance. Renaissance currently has an established 150,000 customer base and is a multimillion dollar company.

For further information:

http://www.XenaCareHoldings.com

Cautionary Note Concerning Forward Looking Statements

Except for the historical and present factual information contained herein, the matters set forth in this document, including statements regarding our anticipated future sales results for our products are forward looking statements. Investors are cautioned that these forward-looking statements are not guarantees of future performance. Actual events or results may differ from the Company’s expectations. There are many risks, uncertainties and other factors that can prevent the achievement of our goals or cause results to differ from those expressed or implied by these forward-looking statements including, without limitation, the risks described in greater detail in filings made by the Company with the Securities and Exchange Commission. The Company assumes no obligation to publicly update or revise its forward-looking statements even if experience or future events make it clear that any of the anticipated results expressed or implied herein will not be realized. The Company’s filings may be accessed at the SEC’s Edgar system at www.sec.gov.

IRVINE, CA–(Marketwire – September 30, 2010) –  Sun Healthcare Group, Inc. (NASDAQ: SUNH) today announced that it will be holding a special stockholder meeting on Thursday, Nov. 4, 2010 at the Irvine Hilton Hotel. At this meeting, stockholders will vote on the previously announced restructuring pursuant to which Sun is separating its operating assets and its real property assets by means of a distribution of SHG Services, Inc. stock. SHG Services, Inc. will own all of Sun’s operating assets and will be renamed Sun Healthcare Group, Inc. Stockholders will also be asked to vote on the merger of Sun with and into Sabra Health Care REIT, Inc., which will own substantially all of Sun’s real property assets, and intends to elect to be treated as a real estate investment trust effective Jan. 1, 2011. As previously announced, Sun expects that the restructuring will be completed in the fourth quarter of 2010.

The record date for stockholders entitled to vote at the meeting is Sept. 15, 2010. Sun expects that a proxy statement/prospectus describing the restructuring transactions will be mailed to stockholders on or about Oct. 4, 2010.

Richard K. Matros, Sun’s Chairman and Chief Executive Officer, commented, “We look forward to the opportunity to create increased shareholder value by separating into two publicly-held companies with independent growth strategies. This meeting is a significant step in the restructuring process.”

About Sun Healthcare Group, Inc.

Sun Healthcare Group, Inc.’s (NASDAQ: SUNH) subsidiaries provide nursing, rehabilitative and related specialty healthcare services principally to the senior population in the United States. Sun’s core business is providing, through its subsidiaries, inpatient services, primarily through 166 skilled nursing centers, 16 combined skilled nursing, assisted and independent living centers, 10 assisted living centers, two independent living centers and eight mental health centers. On a consolidated basis, Sun has annual revenues of $1.9 billion and approximately 30,000 employees in 46 states. At June 30, 2010, SunBridge centers had 23,209 licensed beds located in 25 states, of which 22,427 were available for occupancy. Sun also provides rehabilitation therapy services to affiliated and non-affiliated centers through its SunDance subsidiary, medical staffing services through its CareerStaff Unlimited subsidiary and hospice services through its SolAmor subsidiary. 

Forward-Looking Statements

Statements made in this release that are not historical facts are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995) that involve risks and uncertainties and are subject to change at any time. These forward-looking statements may include, but are not limited to, statements containing words such as “anticipate,” “believe,” “plan,” “estimate,” “expect,” “hope,” “intend,” “may” and similar expressions. Factors that could cause actual results to differ are identified in the public filings made by the Company with the Securities and Exchange Commission (SEC) and include the company’s ability to successfully complete the restructuring on terms and conditions satisfactory to Sun, as well as other risks and uncertainties, including those detailed from time to time in Sun’s SEC Commission filings. More information on factors that could affect the business and financial results are included in the company’s public filings made with the SEC, including our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, copies of which are available on Sun’s web site, www.sunh.com. The forward-looking statements involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Sun’s control. Investors are cautioned that any forward-looking statements made by Sun are not guarantees of future performance. Sun disclaims any obligation to update any such factors or to announce publicly the results of any revisions to any of the forward-looking statements to reflect future events or developments.

Additional Information

In connection with the transactions described in this release, SHG Services, Inc. has filed with the SEC a Registration Statement on Form S-1 and Sabra Health Care REIT, Inc. has filed with the SEC a Registration Statement on Form S-4, each containing an identical prospectus and proxy statement for the special meeting. The definitive proxy statement/prospectus is being mailed to Sun stockholders on or about October 4, 2010. Before making any voting or investment decision, Sun stockholders and investors are urged to read the proxy statement/prospectus and other documents filed with the SEC carefully and in their entirety when they become available because they will contain important information about the proposed transactions. Stockholders will be able to obtain these documents free of charge at the SEC’s web site at www.sec.gov. In addition, investors and stockholders of Sun may obtain free copies of the documents filed with the SEC by contacting Sun’s investor relations department at (505) 468-2341 (TDD users, please call (505) 468-4458) or by sending a written request to Investor Relations, Sun Healthcare Group, Inc. 101 Sun Avenue N.E., Albuquerque, N.M. 87109. Investors and stockholders may also obtain a copy of these documents by requesting them in writing from Sun’s proxy solicitation agent, Innisfree M&A, at 501 Madison Avenue, New York, NY 10022, or by telephone at (212) 750-5833. 

Sun and its directors and executive officers and other members of its management and employees may be deemed to be participants in the solicitation of proxies from the stockholders of Sun in connection with the transactions described in this release. Information about the directors and executive officers of Sun and their ownership of shares of Sun common stock are set forth in the Annual Report on Form 10-K for the year ended December 31, 2009 filed with the SEC on March 5, 2010 and in the definitive proxy statement relating to Sun’s 2010 Annual Meeting of Stockholders filed with the SEC on April 30, 2010. These documents can be obtained free of charge from the sources indicated above. Additional information regarding the interests of these participants is also included in the definitive proxy statement/prospectus regarding the proposed transactions that is being mailed to Sun stockholders on or about October 4, 2010.

METHUEN, MA–(Marketwire – September 30, 2010) –  Suntron Corporation, a leader in the area of integrated Electronics Manufacturing Solutions (EMS) and Commercial Off-The Shelf (COTS) technology, with facilities across the US and in Mexico, will cut the ribbon at its new manufacturing site in Methuen, MA at 1:00 PM, October 05, 2010.

This new facility is the culmination of months of effort to combine the work previously done in two separate sites, into a larger, newer, state of the art facility. “The move to combine our northeast services under one roof clearly demonstrates Suntron’s commitment to the region and to our customers,” Roger White, VP and General Manager of the Eastern Region, stated. “We have expanded our box build manufacturing footprint and with significant capital investment, we are expanding our circuit card capacity and capabilities. I look forward to introducing everyone to the exciting new facility.”

Mike Churchill, VP of Operations for Suntron, commented on the teamwork needed to put this together. “We had amazing cooperation from so many local people and organizations, including our team of realtors from Colliers Meredith and Grew, the City of Methuen, the local Merrimack Chamber of Commerce, and the Massachusetts Business Development and Business Services groups. Their total support and guidance allowed us to accomplish our objectives in a very timely manner and we look forward to introducing everyone to our exciting new facility.”

The grand opening and ribbon cutting ceremony will be hosted by Ed Wheeler, President and CEO of Suntron. Lt. Governor Timothy P. Murray, Congresswoman Niki Tsongas, Mayor William M. Manzi, III and Joe Bevilacqua, President and CEO of the Merrimack Chamber of Commerce will all participate at the event. Factory tours will begin immediately following the ceremony.

For further information on this event and the day’s agenda, please visit http://www.suntroncorp.com.

About Suntron Corporation:
Suntron delivers complete manufacturing services and solutions to support the entire life cycle of complex products in the medical, aerospace & defense, Industrial, Networking & telecommunications, and semiconductor capital equipment market segments. Headquartered in Phoenix, Suntron operates four full-service manufacturing facilities and two quick-turn facilities in North America. Suntron’s services include engineering services, printed circuit card assembly, box build, large scale and complex system integration, COTS and test.

PERTH, AUSTRALIA–(Marketwire – September 29, 2010) –  After three years of collaborative research involving patients from The Busselton Health Study, drug discovery company Proteomics International announced the identification and analytical validation of 13 protein biomarkers for a significant complication of diabetes — diabetic nephropathy (kidney disease). In a presentation at the Human Proteome Organisation’s World Congress in Sydney, Australia, Dr. Richard Lipscombe, Managing Director of Proteomics International, revealed the findings that could benefit many of the 250 million people worldwide who have diabetes.

“Applying our uniquely accredited proteomics biomarker expertise to patient samples (plasma) from the Busselton Health Study and the Fremantle Diabetes Study allowed us to analyze three well characterized clinical cohorts of selected disease groups (adults who had Type II diabetes and diabetic nephropathy),” said Dr. Lipscombe. “The protein biomarkers that we found could now allow for the prediction of those patients who would progress to the development of kidney disease and provide new targets for drug therapies that prevent the onset of this serious complication.“

Proteomics International is actively seeking partners to further qualify and commercialize its patented diabetes biomarker portfolio.

The protein biomarker discovery and validation approach included the analysis of pooled plasma samples for differential protein expression, i.e. proteins that are found at different levels in the diabetic disease state relative to the normal diabetic state. Candidate biomarkers were identified from iTRAQ labelled samples by 2D-LC MALDI TOF/TOF mass spectrometry, an emerging technique in proteomics. This discovery phase identified 130-200 proteins per cohort and across all studies over 50 proteins showed significant differences in concentrations. Biomarker candidates were validated in a second approach using the advanced mass spectrometry technique Selected or Multiple Reaction Monitoring (SRM/MRM) to carry out concentration analysis on individual patient plasma samples. Statistical data analysis of the validation phase identified 13 putative protein biomarkers for diabetic nephropathy across the studies, including proteins involved in metabolism, inflammation and oxidative stress. The complexity of the diabetic kidney disease suggests that there would not necessarily be one biomarker but a set of biomarkers (signature) in varying degrees to characterize the diabetic nephropathy state. These biomarkers can be used as diagnostic tools or new drug targets.

About Proteomics International Pty Ltd
Proteomics International is both a drug discovery company and contract research service provider. Proteomics International combines the most advanced high throughput mass spectrometry instrumentation (MALDI TOF-TOF and LC-MS/MS) and a team of qualified scientists with proven expertise in protein and peptide chemistry. Proteomics International is the only company globally to achieve laboratory accreditation to International Standard ISO/IEC 17025:2005 for provision of proteomics services. The accreditation is a widely used benchmark for US Federal testing facilities and strengthens the company’s licensing position to deliver drug development data that is of the highest scientific integrity. The company has two focal research activities: new peptide drugs from venoms, and the discovery and use of biomarkers; both analyses build upon its proprietary transformative Bioven process.

HOUSTON, TX–(Marketwire – September 29, 2010) –  DHEA (Dehydroepiandrosterone) is the most abundant base building block for hormones in our bodies. We gradually make more and more DHEA until about age 25; then produce less and less as time passes. By age 35, the right DHEA supplement can provide noticeable advantages to help us look and feel our best and diminish many aspects of aging. But it must be used correctly.

Medical research shows DHEA must be delivered to the body as a transdermal cream rather than as a pill supplement.

Oral DHEA taken as a pill is destroyed by the “first-pass effect” of the liver. The liver filters out most DHEA before it can do any good; what does get into the bloodstream is DHEA-S (DHEA sulphate).

DHEA-S is a different pro-hormone and has different benefits than DHEA. Medical research shows DHEA is converted into DHEA-S, but not the other way around. DHEA-S is not converted by the body into DHEA. (Hammer et al)

Twist 25 supplements DHEA rather than DHEA-S.

Most research studies of “DHEA” were done using oral DHEA. As a consequence these studies showed little significant benefit to “DHEA”(sulphate) supplementation. No wonder: These studies did not test DHEA with the proper method of administration.

DHEA must be delivered to the body properly as a transdermal DHEA cream – Twist 25.

Medical research shows the human body metabolizes most DHEA into other hormones in the skin (the dermis). The skin is where we use most of the DHEA we make. So Twist 25 cream actually provides exactly what the body produces naturally (bioidentical DHEA) where we use it (in the skin). (Labrie et al)

This is the other key reason DHEA should be provided to the body as a transdermal DHEA cream – Twist 25.

Twist 25 DHEA supplement cream is the highest quality most effective anti-aging health product available. Twist 25 is tested for safety and efficacy.

About Health2Go, Inc.
Health2Go, Inc. develops, manufactures and provides leading-edge top quality anti-aging products. To learn more about Health2Go, Inc. or their anti-aging and wellness products, please visit www.twist25.com or http://store.twist25.com

Fabian Hammer, Sandra Subtil, Philipp Lux, Christiane Maser-Gluth, Paul M. Stewart, Bruno Allolio and Wiebke Arlt. No Evidence for Hepatic Conversion of Dehydroepiandrosterone (DHEA) Sulphate to DHEA: In Vivo and in Vitro Studies. Journal of Clinical Endochrinology and Metabolism Vol. 90, No. 6 3600-3605

Fernand Labrie, Alain Belanger, Rene Berube, et al. University of Toronto Medical School. The Journal of Steroid Biochemistry and Molecular Biology Vol 103, Issue 2, February 2007, Pgs 178-188

Click here to see all recent news from this company

MUNDELEIN, IL–(Marketwire – September 29, 2010) –  Despite traditional differences among the chief constituents of long-term care, the new survey process can be a “win-win” for everyone, which will drive significant quality improvements in our nation’s nursing homes, said Kansas Governor Mark Parkinson and the incoming president of the American Health Care Association and National Center for Assisted Living (AHCA/NCAL), the nation’s largest long-term care association. Governor Parkinson made these comments while speaking at Medline Industries, Inc.’s second annual Long-Term Care Quality Summit, in New York City. More than 150 leaders from the nation’s long-term care community are attending the two-day forum focused on how nursing homes can meet the changing expectations for quality among their residents and families.

“Historically there has been mistrust among providers, regulators and advocacy groups over the traditional survey process and what its goals are,” said Governor Parkinson. “But I am optimistic now because we all want quality care in our nursing homes, and the new Quality Indicator Survey (QIS) process can help make this happen.”

Governor Parkinson said the QIS is more objective than the traditional survey process and focuses on important quality criteria, including a robust care plan, promoting a safe environment and keeping residents active. He emphasized that for resident quality to improve, it was crucial that these criteria be measured and homes be held accountable to maintaining high standards.

In addition to Governor Parkinson, topics being discussed at the Summit include the changing regulatory expectations for the long-term care industry and how nursing homes can implement a system to continuously improve quality of care and life for their residents.

Other speakers include: Anthony Rodgers, new CMS Deputy Administrator for the Center for Strategic Planning; Robert F. Kennedy, Jr.; Andy Kramer, MD, chief executive officer of Nursing Home Quality and professor of medicine, University of Colorado; Neil Pruitt, Jr., chairman and CEO, UHS Pruitt Corporation; Jim Foy, president and CEO, St. John’s Riverside Healthcare System, Yonkers, NY; Barbara Baylis, senior vice president of clinical operations, Kindred Healthcare, Inc.; Mary Ousley, president of Ousley & Associates; Elizabeth Ayello, president of Ayello, Harris and Associates; and Kevin Yankowsky, partner in the health law litigation group of Fulbright & Jaworski L.L.P.

About Medline Industries, Inc. 
Medline, the nation’s largest privately held manufacturer and distributor of healthcare products, manufactures and distributes more than 100,000 products to hospitals, extended-care facilities, surgery centers, home care dealers and agencies. Headquartered in Mundelein, Ill., Medline has more than 900 dedicated sales representatives nationwide to support its broad product line and cost management services.

Over the past five years, Medline has been the fastest-growing distributor of medical and surgical supplies in the U.S., serving as the primary distributor to over 450 major hospitals and healthcare systems. As a leading distributor, Medline offers a comprehensive array of consulting and management services encompassing the supply chain and logistics, utilization and standardization, business tools and enhanced reporting capabilities and on-staff clinicians.

TAMPA, FL–(Marketwire – September 29, 2010) –  Sage North America today announced that the Sage Healthcare Division, a major provider of electronic health records (EHR) and practice management software serving approximately 80,000 physicians throughout the United States, has been named a preferred vendor by the Ohio Health Information Partnership to make available the Sage Intergy Meaningful Use Edition to all of the Regional Extension Center’s (REC) thousands of participating healthcare providers.

The Ohio Health Information Partnership (OHIP) is a nonprofit, funded through a combination of state funds and federal grants, whose mission is to advance the adoption, implementation and meaningful use of health IT among health care providers to improve the safety, quality, accessibility, availability and efficiency of healthcare for the citizens of Ohio. The organization was created by the American Recovery and Reinvestment Act (ARRA).

Fred Richards, CIO and COO of OHIP, said, “We look forward to working with Sage Healthcare to help us achieve our mission to improve the quality and value of health in Ohio by increasing the use of EHRs.”

The Ohio partnership will provide services that will offer practices EHR implementation assistance making the selection of an EHR system easier for healthcare providers, as well as helping providers meet meaningful use standards. Meeting these standards is necessary for physicians to qualify for financial incentives through Medicare and Medicaid.

The overall goal of OHIP is to improve healthcare quality, outcomes and experience for the citizens of Ohio. OHIP is committed to assisting more than 6,000 physicians adopt and meaningfully use an EHR by 2012.

As a Preferred Vendor for OHIP, Sage will be offering its electronic health record products and services to OHIP provider members. “The Sage mission echoes that of the Ohio Information Partnership in that our ultimate goal is to improve healthcare outcomes throughout the United States through the implementation of affordable and effective health information technology,” said Ken Ernsting, Vice President of Business Development for Sage Healthcare. “Because of this mission, Sage is dedicated to serving regional extension centers and the provider community here in Ohio and beyond.”

The Sage Intergy Meaningful Use Edition is a comprehensive clinical, financial and administrative health information technology solution that assists physicians in continuing to advance the quality and efficiency of care they deliver. The Sage Intergy family of products includes integrated practice management, electronic health records, clinical and business intelligence and tools for online patient engagement. Providers can access Sage Intergy from multiple practice locations, from home, or other remote locations either through a central patient database server, or as a Sage-hosted solution on a monthly subscription basis.

Sage Intergy easily tracks the details of a patient’s clinical history, shares and manages clinical information and combines complex medical practice functions into easy-to-navigate menus. Sage Intergy features centralized financial operations including billing, reporting, task management, and fully integrates with EDI services, Sage Intergy Practice Portal, Sage Intergy RIS and Sage Practice Analytics.

Clinics eligible to utilize Ohio Health Information Partnership’s subsidized services include Priority Primary Care Providers (PPCP) in the area of family medicine, obstetrics, and gynecology, general internal or pediatric medicine. In addition, practices must be either individual or a small group practices (defined as 10 or fewer professionals with prescriptive privileges in the practice) primarily focused on primary care; public and critical access hospitals; and community health centers and rural health clinics.

About Ohio Health Information Partnership
Ohio Health Information Partnership mission is to advance the adoption, implementation and meaningful use of health IT among healthcare providers and facilitate and develop an electronic health information exchange (HIE) to improve the safety, quality, accessibility, availability and efficiency of healthcare for the citizens of Ohio while creating a secure, sustainable health information exchange that ensures the protection of all patient records, enables providers to access necessary, patient-authorized health information and improves the overall level of health care provided throughout the state of Ohio.

About Sage Healthcare Division
Sage Healthcare Division provides integrated electronic health records, EDI applications and practice management systems to approximately 80,000 physicians and thousands of ambulatory care practices throughout North America. These systems enable physicians and practice managers to better manage their practices and improve profitability. Sage Healthcare Division is based in Tampa, Fla., and is a division of Sage North America. For more information, please visit www.sagehealth.com or call (877) 932-6301.

About Sage North America
Sage North America is part of The Sage Group plc, a leading global supplier of business management software and services. Sage North America employs 4,000 people and supports 3.1 million small and midsized business customers, including medical practices in the United States. The Sage Group plc, formed in 1981, was floated on the London Stock Exchange in 1989 and now employs 13,100 people and supports 6.2 million customers worldwide. For more information, please visit the Web site at www.sagenorthamerica.com.

© 2010 Sage Software, Inc. All rights reserved. Sage, the Sage logos, and the Sage product and service names mentioned herein are registered trademarks or trademarks of Sage Software, Inc. or its affiliated entities. All other trademarks are the property of their respective owners.